Literature DB >> 9797623

Outcome at 5-6 years of prematurely born children who received morphine as neonates.

R MacGregor1, D Evans, D Sugden, T Gaussen, M Levene.   

Abstract

AIM: To assess outcome at 5-6 years in a cohort of very preterm infants (< 34 weeks of gestation) who had been randomly allocated within a controlled clinical trial to receive morphine or non-morphine treatment in the neonatal period.
METHODS: Assessments were made on 87 children at 5-6 years who had been recruited in the neonatal period to two sequential controlled studies (1989-92). Infants requiring mechanical ventilation had been randomly allocated to receive either morphine (n = 62) or other (n = 33) solutions starting on the first day of life. Each child was seen by a single experienced observer and assessed at 5-6 years using the WPPSI-R, Movement ABC, and the Child Behaviour Checklist. The performance of children exposed to morphine was compared with that of those in the non-morphine group. Blood samples for thyroid stimulating hormone (TSH) measurement were obtained from children whose parents gave consent.
RESULTS: There was no significant difference in any of the three test scales between infants in the two groups, but there was a trend towards better performance in all three tests in the morphine group. Assessment of TSH values in a subgroup of the survivors showed no difference in thyroid function between the two groups.
CONCLUSION: Exposure to morphine in the neonatal period to facilitate mechanical ventilation does not seem to have any adverse effects on intelligence, motor function, or behaviour when these children are assessed at 5-6 years of age.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9797623      PMCID: PMC1720823          DOI: 10.1136/fn.79.1.f40

Source DB:  PubMed          Journal:  Arch Dis Child Fetal Neonatal Ed        ISSN: 1359-2998            Impact factor:   5.747


  15 in total

1.  Effect of morphine and pancuronium on the stress response in ventilated preterm infants.

Authors:  M W Quinn; F Otoo; J A Rushforth; H G Dean; J W Puntis; J Wild; M I Levene
Journal:  Early Hum Dev       Date:  1992-10       Impact factor: 2.079

2.  Visualization of mu opiate receptor downregulation following morphine treatment in neonatal rat brain.

Authors:  A Tempel
Journal:  Brain Res Dev Brain Res       Date:  1991-12-17

3.  Development of infants of drug dependent mothers.

Authors:  A van Baar
Journal:  J Child Psychol Psychiatry       Date:  1990-09       Impact factor: 8.982

4.  Perinatal opiate treatment delays growth of cortical dendrites.

Authors:  A A Ricalde; R P Hammer
Journal:  Neurosci Lett       Date:  1990-07-31       Impact factor: 3.046

5.  Opioid antagonist-induced modulation of cerebral and hippocampal development: histological and morphometric studies.

Authors:  I S Zagon; P J McLaughlin
Journal:  Brain Res       Date:  1986-08       Impact factor: 3.252

6.  Stress, severity of illness, and outcome in ventilated preterm infants.

Authors:  D P Barker; N Rutter
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1996-11       Impact factor: 5.747

7.  Morphine glucuronidation in premature neonates.

Authors:  R Hartley; M Quinn; M Green; M I Levene
Journal:  Br J Clin Pharmacol       Date:  1993-03       Impact factor: 4.335

8.  Effects of opiates on neuronal development in the rat cerebral cortex.

Authors:  J V Seatriz; R P Hammer
Journal:  Brain Res Bull       Date:  1993       Impact factor: 4.077

Review 9.  Effects of opiates on brain development.

Authors:  R P Hammer; A A Ricalde; J V Seatriz
Journal:  Neurotoxicology       Date:  1989       Impact factor: 4.294

10.  A longitudinal study of offspring born to methadone-maintained women. III. Effects of multiple risk factors on development at 4, 8, and 12 months.

Authors:  J Marcus; S L Hans; R J Jeremy
Journal:  Am J Drug Alcohol Abuse       Date:  1984       Impact factor: 3.829

View more
  21 in total

Review 1.  Pharmacological therapy for analgesia and sedation in the newborn.

Authors:  K J S Anand; R W Hall
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2006-11       Impact factor: 5.747

Review 2.  Acupuncture in the neonatal intensive care unit-using ancient medicine to help today's babies: a review.

Authors:  K L Chen; I Quah-Smith; G M Schmölzer; R Niemtzow; J L Oei
Journal:  J Perinatol       Date:  2016-12-15       Impact factor: 2.521

3.  Sedation and analgesia in mechanically ventilated preterm neonates: continue standard of care or experiment?

Authors:  Christopher McPherson
Journal:  J Pediatr Pharmacol Ther       Date:  2012-10

Review 4.  Anesthesia and analgesia in the NICU.

Authors:  R Whit Hall
Journal:  Clin Perinatol       Date:  2012-03       Impact factor: 3.430

Review 5.  Long-term impact of neonatal injury in male and female rats: Sex differences, mechanisms and clinical implications.

Authors:  Jamie L LaPrairie; Anne Z Murphy
Journal:  Front Neuroendocrinol       Date:  2010-02-06       Impact factor: 8.606

Review 6.  Pain management in newborns.

Authors:  Richard W Hall; Kanwaljeet J S Anand
Journal:  Clin Perinatol       Date:  2014-10-07       Impact factor: 3.430

7.  Neonatal morphine exposure in very preterm infants-cerebral development and outcomes.

Authors:  Rachel Steinhorn; Christopher McPherson; Peter J Anderson; Jeffrey Neil; Lex W Doyle; Terrie Inder
Journal:  J Pediatr       Date:  2015-05       Impact factor: 4.406

Review 8.  The long-term impact of early life pain on adult responses to anxiety and stress: Historical perspectives and empirical evidence.

Authors:  Nicole C Victoria; Anne Z Murphy
Journal:  Exp Neurol       Date:  2015-07-22       Impact factor: 5.330

9.  Neonatal procedural pain and preterm infant cortisol response to novelty at 8 months.

Authors:  Ruth E Grunau; Joanne Weinberg; Michael F Whitfield
Journal:  Pediatrics       Date:  2004-07       Impact factor: 7.124

10.  Smaller Cerebellar Growth and Poorer Neurodevelopmental Outcomes in Very Preterm Infants Exposed to Neonatal Morphine.

Authors:  Jill G Zwicker; Steven P Miller; Ruth E Grunau; Vann Chau; Rollin Brant; Colin Studholme; Mengyuan Liu; Anne Synnes; Kenneth J Poskitt; Mikaela L Stiver; Emily W Y Tam
Journal:  J Pediatr       Date:  2016-01-04       Impact factor: 4.406

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.